Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.
- NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_assertion description "[These data indicate that in addition to its effects on growth, survival, and motility, ERK activation in MM attenuates a host antitumor immune response, implicating CD200 and its interaction with the CD200 receptor as a potential therapeutic target for MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.
- NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_assertion evidence source_evidence_literature NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.
- NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_assertion SIO_000772 18008004 NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.
- NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_assertion wasDerivedFrom befree-20140225 NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.
- NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_assertion wasGeneratedBy ECO_0000203 NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP715387.RA6gJG1mW31LeNQ0VKddP7b3HzBm5V7kx4PMnijA-tXCA130_provenance.